Program Year 2020
General Payments491,832 providers 1,650 companies
Dataset totals — PY2020
$1,687,222,531.65
- Category: General Payments
- Program year: 2020
- Records: 5,817,353
- Providers: 491,832
- Reporting companies: 1,650
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- Dataset-level totals for the labeled program year, General Payments only. Research and Ownership/Investment are separate datasets and are never combined into these figures.
- Methodology & Data — sourcing, labeling, and limitations.
Coverage: program years 2018–2024 are loaded, General Payments only. This page reflects the CMS publication snapshot for PY2020.
Reported totals by company — PY2020 (20 shown)
Sorted by reported total — a dataset fact, not a ranking of conduct.
| Company | Reported | Records | Providers |
|---|---|---|---|
| Medtronic Vascular, Inc. | $103,778,643.26 | 70,270 | 15,181 |
| Arthrex, Inc. | $89,575,054.24 | 20,406 | 2,521 |
| Zimmer Biomet Holdings, Inc. | $73,998,683.35 | 48,060 | 14,872 |
| Stryker Corporation | $67,848,109.74 | 55,714 | 14,697 |
| DePuy Synthes Products LLC | $65,415,833.71 | 1,746 | 331 |
| Medtronic USA, Inc. | $63,957,289.62 | 49,591 | 11,992 |
| Allergan Inc. | $61,310,455.05 | 347,046 | 69,373 |
| Medtronic MiniMed, Inc. | $40,633,973.30 | 6,341 | 2,436 |
| Smith & Nephew, Inc. | $31,903,755.91 | 38,244 | 12,355 |
| Acerta Pharma LLC | $30,443,150.39 | 308,984 | 63,831 |
| INTUITIVE SURGICAL, INC. | $29,802,924.05 | 48,544 | 7,734 |
| BOSTON SCIENTIFIC CORPORATION | $29,239,529.96 | 86,963 | 26,728 |
| Lilly USA, LLC | $25,027,175.39 | 180,652 | 42,654 |
| Merck Sharp & Dohme Corporation | $24,161,948.85 | 116,077 | 48,813 |
| ABBVIE INC. | $23,554,552.87 | 200,269 | 47,527 |
| PFIZER INC. | $20,616,349.44 | 188,580 | 65,995 |
| Paragon 28, Inc. | $20,451,428.65 | 1,826 | 875 |
| Amgen Inc. | $19,997,209.79 | 231,211 | 56,131 |
| Abbott Laboratories | $17,918,791.55 | 115,232 | 21,553 |
| NuVasive, Inc. | $17,145,948.59 | 7,793 | 1,291 |
Reported totals by specialty — PY2020 (20 shown)
Sorted by reported total.
Other program years
Natures of payment
- Royalty or License
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
- Consulting Fee
- Food and Beverage
- Acquisitions
- Travel and Lodging
- Education
- Honoraria
- Current or prospective ownership or investment interest
- Grant
- Compensation for serving as faculty or as a speaker for a medical education program
- Gift
- Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program
- Debt forgiveness
- Long term medical supply or device loan
- Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program
- Charitable Contribution
- Entertainment